Chondroitin sulfate proteoglycan 4 (CSPG4) is a type I transmembrane protein widely expressed across multiple malignant tumors, including melanoma, triple-negative breast cancer, mesothelioma, and sarcoma [74]. This evidence concerns the gene CSPG4 and sarcoma.